From the time of diagnosis, annual monitoring for deficiencies of TSH, GH, LH, and FSH is indicated.

Surveillance of skin for premalignant lesions may be necessary depending on latitude and history of sun exposure. Malignant skin lesions have not specifically been reported to be associated with POMC deficiency, though a theoretic risk is assumed to exist.
